Product Images Losartan Potassium 50 Mg

This appears to be a graph or chart showing the percentage of patients with a primary endpoint for two different medications, Atenolol and Sartan Potassium. The graph also shows an adjusted risk reduction of 13% with a p-value of 0.021. The numbers on the bottom of the graph correspond to study months.*

This appears to be a graph or table showing the percentage of patients who experienced fatal or non-fatal strokes over the course of a study that lasted 66 months. The two treatments being compared are Atenolol and Losartan Potassium. However, without further context or information it is difficult to interpret the data accurately.*

This is a table presenting the primary composite stroke (fatal/non-fatal) results from a study of two medications, Losartan Potassium and Atenolol. The table provides the number of events and the rate of events that occurred in patients taking each medication, categorized by age, gender, race, and other factors such as hypertension, diabetes, and history of cardiovascular disease. The table also includes hazard ratios for each category, with 95% confidence intervals, and graphs showing the relative risks compared to placebo.*

This Could be a graph representation of Risk Reduction and patients with occurrences of events. Without further context, it is not possible to provide a meaningful description.*

Losartan Potassium is a prescription drug that belongs to a class of medicines used to treat high blood pressure (hypertension). It comes in the form of 50mg tablets packed in bottles of 90 tablets each. The tablets are white, round, biconvex, film-coated, with "12" debossed on one side and plain on the other. Losartan Potassium is manufactured in India by Vivimed Life Sciences and is distributed in the United States by Proficient Rx LP. The drug should be stored at room temperature and kept out of the reach of children. The package contains a lot number, expiration date, and a barcode with the GTIN number.*